Infinity Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Infinity Pharmaceuticals's estimated annual revenue is currently $1.8M per year.
- Infinity Pharmaceuticals's estimated revenue per employee is $5,014
- Infinity Pharmaceuticals's total funding is $538M.
- Infinity Pharmaceuticals's current valuation is $121.1M. (January 2022)
Employee Data
- Infinity Pharmaceuticals has 367 Employees.
- Infinity Pharmaceuticals grew their employee count by -4% last year.
Infinity Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Medical Officer | Reveal Email/Phone |
2 | VP, Clinical Development Operations | Reveal Email/Phone |
3 | Head Pharmaceutical Development | Reveal Email/Phone |
4 | VP, Quality | Reveal Email/Phone |
5 | Senior Medical Director | Reveal Email/Phone |
6 | Director, Human Resources | Reveal Email/Phone |
7 | Director Translational Science | Reveal Email/Phone |
8 | Chief Business Officer | Reveal Email/Phone |
9 | Associate Director, Quality Operations | Reveal Email/Phone |
10 | Associate Director, Financial Planning & Analysis | Reveal Email/Phone |
Infinity Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $413.3M | 324 | 0% | $634M | N/A |
#2 | $47.8M | 238 | 0% | N/A | N/A |
#3 | $2.4M | 12 | -52% | N/A | N/A |
#4 | $25.7M | 128 | 39% | N/A | N/A |
#5 | $12.9M | 64 | 129% | N/A | N/A |
#6 | $23.9M | 119 | 8% | $113M | N/A |
#7 | $0.3M | 3 | 0% | N/A | N/A |
#8 | $10.3M | 51 | -14% | N/A | N/A |
#9 | $1.8M | 367 | -4% | $538M | N/A |
#10 | $50M | 249 | 3% | N/A | N/A |
What Is Infinity Pharmaceuticals?
Infinity Pharmaceuticals, Inc., based in Boston, Massachusetts, was founded in 2001 by world leaders in chemistry, genomic biology, medicine, software, and business. The company is committed to improving human health by changing drug discovery to bring important new medicines to patients. Infinity's initial drug discovery efforts are focused on cancer, metabolic disorders, infectious disease and inflammatory disease.
keywords:N/A
$538M
Total Funding
367
Number of Employees
$1.8M
Revenue (est)
-4%
Employee Growth %
$121.1M
Valuation
N/A
Accelerator
Infinity Pharmaceuticals News
Infinity Pharmaceuticals (NASDAQ:INFI Get Rating) will post its quarterly earnings results after the market closes on Tuesday, May 3rd.
(Infinity or the Company), is a clinical-stage biotechnology company developing eganelisib (IPI-549), a first-in-class, oral, immuno-...
Shares of Infinity Pharmaceuticals (INFI +26.6%) rose after reporting better-than-expected FY revenue from royalties.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced a $20 million non-dilutive asset-backed financing with BVF Partners L.P., Infinity’s largest shareholder. This investment by BVF entails no equity to be issued by Infinity and has its sole recourse i ...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $79.9M | 368 | 8% | $174M |
#2 | $96.9M | 369 | 48% | N/A |
#3 | $57.7M | 372 | -23% | $170M |
#4 | $57.8M | 373 | -86% | N/A |
#5 | $153.2M | 377 | -3% | N/A |